Research Article
Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
Table 1
Prognosis analysis top 50 differentially expressed genes in GBM.
| | Genes | Overall survival | Progression-free survival | Disease-specific survival | | value | HR (95% CI) | value | HR (95% CI) | value | HR (95% CI) |
| | CD163 | 0.0437 | 1.45 (1.01-2.09) | 0.012 | 1.60 (1.11-2.30) | 0.048 | 1.48 (1.00-2.17) | | CHI3L2 | 0.0077 | 1.61 (1.12-2.33) | 0.0063 | 1.64 (1.14-2.37) | 0.022 | 1.58 (1.07-2.35) | | TOP2A | — | — | 0.006 | 0.60 (0.42-0.86)) | — | — | | MMP9 | — | — | 0.044 | 1.45 (1.01-2.09) | — | — | | NUSAP1 | — | — | 0.029 | 0.67 (0.47-0.96) | — | — | | PIMREG | — | — | 0.007 | 0.60 (0.42-0.87) | — | — | | F2R | — | — | 0.038 | 0.68 (0.47-0.98) | — | — | | AURKB | — | — | 0.026 | 0.66 (0.46-0.95) | — | — | | PDPN | — | — | 0.002 | 1.79 (1.24-2.59) | — | — | | ANXA1 | — | — | 0.022 | 1.53 (1.06-2.21) | — | — | | KIFC1 | — | — | 0.038 | 0.68 (0.48-0.98) | — | — | | PI3 | — | — | 0.033 | 1.48 (1.03-2.13) | — | — | | SAA1 | 0.033 | 1.49 (1.03-2.15) | 0.042 | 1.46 (1.01-2.11) | — | — | | TGFBI | 0.019 | 1.55 (1.07-2.24) | — | — | 0.016 | 1.62 (1.09-2.40) | | PACSIN1 | 0.027 | 1.51 (1.05-2.18) | — | — | 0.035 | 1.52 (1.03-2.26) | | SULT4A1 | 0.023 | 1.52 (1.06-2.19) | — | — | 0.025 | 1.56 (1.06-2.30) | | VSNL1 | 0.012 | 1.59 (1.11-2.27) | — | — | 0.039 | 1.50 (1.02-2.20) | | SV2B | 0.006 | 1.66 (1.15-2.39) | — | — | 0.018 | 1.60 (1.08-2.37) | | CHGA | 0.016 | 1.57 (1.09-2.27) | — | — | 0.033 | 1.54 (1.04-2.28) | | SNCB | 0.010 | 1.61 (1.12-2.32) | — | — | 0.039 | 1.51 (1.02-2.22) | | SLC12A5 | 0.005 | 1.70 (1.18-2.46) | — | — | 0.005 | 1.76 (1.19-2.62) | | NRGN | 0.035 | 1.48 (1.03-2.14) | — | — | 0.099 | 1.39 (0.94-2.06) | | CPLX2 | 0.039 | 1.48 (1.02-2.14) | — | — | — | — | | CREG2 | 0.031 | 1.49 (1.04-2.15) | — | — | — | — |
|
|
